Tetanus vaccination, antibody persistence and decennial booster; Reply to 'New guidelines about tetanus vaccination schedules in Europe should be evaluated with caution' by Eldin and co-workers.
作者信息
Borella-Venturini M, Frasson C, Paluan F, DE Nuzzo D, DI Masi G, Giraldo M, Chiara F, Trevisan A
机构信息
Dipartimento di Scienze Cardiologiche,Toraciche e Vascolari,Università di Padova,Italy.
出版信息
Epidemiol Infect. 2017 Oct;145(13):2777-2778. doi: 10.1017/S0950268817001741. Epub 2017 Aug 14.
Abstract
摘要
相似文献
1
Tetanus vaccination, antibody persistence and decennial booster; Reply to 'New guidelines about tetanus vaccination schedules in Europe should be evaluated with caution' by Eldin and co-workers.破伤风疫苗接种、抗体持久性及十年一次的加强免疫；对埃尔丁及其同事所著《欧洲破伤风疫苗接种计划新指南应谨慎评估》的回复
Epidemiol Infect. 2017 Oct;145(13):2777-2778. doi: 10.1017/S0950268817001741. Epub 2017 Aug 14.
2
Letter to the Editor: New guidelines about tetanus vaccination schedules in Europe should be evaluated with caution; Comment on: Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers. By Borrella-Venturini et al.致编辑的信：欧洲破伤风疫苗接种时间表的新指南应谨慎评估；评论：破伤风疫苗接种、抗体持久性及十年一次的加强免疫：一项针对大学生和高危工作者的血清学调查。作者：博雷拉 - 文图里尼等人
Epidemiol Infect. 2017 Oct;145(13):2779-2780. doi: 10.1017/S0950268817001765. Epub 2017 Aug 14.
3
Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.对年轻成年人进行为期十年的含有两种不同铝浓度的低抗原含量白喉、破伤风、无细胞百日咳疫苗接种管理。
Vaccine. 2015 Jun 12;33(26):3026-34. doi: 10.1016/j.vaccine.2014.10.049. Epub 2015 Jan 19.
4
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗（Boostrix®）：作为单剂加强免疫的特性和用途介绍。
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
5
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.5 岁时接种过 3、5、11 月龄六联苗（DTaP-HBV-IPV/Hib）的儿童的免疫持久性。
Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494.
6
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.十年期联合低抗原含量白喉-破伤风-无细胞百日咳和灭活脊髓灰质炎病毒加强疫苗（dTpa-IPV）在健康成年人中的免疫原性和反应原性。
Vaccine. 2015 May 21;33(22):2594-601. doi: 10.1016/j.vaccine.2015.03.104. Epub 2015 Apr 14.
7
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.成人接种含低剂量抗原的白喉-破伤风-无细胞百日咳疫苗（Tdap）初免加强后 9 年，抗体持久性、安全性和免疫原性。
Vaccine. 2018 Oct 8;36(42):6325-6333. doi: 10.1016/j.vaccine.2018.08.051. Epub 2018 Sep 7.
8
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.母亲接种白喉-破伤风-无细胞百日咳疫苗对幼儿百日咳加强免疫反应的影响：一项随机试验的随访。
Vaccine. 2021 Mar 12;39(11):1598-1608. doi: 10.1016/j.vaccine.2021.02.001. Epub 2021 Feb 19.
9
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.一项 III 期、开放性标签、随机多中心研究，旨在评估在英国 3 至 4 岁健康儿童中，同时接种麻疹-腮腺炎-风疹疫苗时，两种不同低剂量抗原白喉-破伤风-无细胞百日咳-脊髓灰质炎疫苗加强剂量的免疫原性和安全性。
Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22.
10
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.青少年首针加强免疫 10 年后接种含低含量抗原白喉破伤风联合无细胞百日咳疫苗的二价加强免疫的免疫原性和安全性：一项开放、III 期、非随机、多中心研究。
Hum Vaccin Immunother. 2018;14(8):1977-1986. doi: 10.1080/21645515.2018.1460292. Epub 2018 May 10.
引用本文的文献
1
An Unusual Case of Evolving Localized Tetanus Despite Prior Immunization and Protective Antibody Titer.尽管之前进行了免疫接种且保护性抗体滴度正常，但仍出现进行性局限性破伤风的罕见病例。
Cureus. 2020 Jul 31;12(7):e9498. doi: 10.7759/cureus.9498.
本文引用的文献
1
Letter to the Editor: New guidelines about tetanus vaccination schedules in Europe should be evaluated with caution; Comment on: Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers. By Borrella-Venturini et al.致编辑的信：欧洲破伤风疫苗接种时间表的新指南应谨慎评估；评论：破伤风疫苗接种、抗体持久性及十年一次的加强免疫：一项针对大学生和高危工作者的血清学调查。作者：博雷拉 - 文图里尼等人
Epidemiol Infect. 2017 Oct;145(13):2779-2780. doi: 10.1017/S0950268817001765. Epub 2017 Aug 14.
2
Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers.破伤风疫苗接种、抗体持久性与十年一次的加强免疫：一项针对大学生和高危工作者的血清学调查
Epidemiol Infect. 2017 Jul;145(9):1757-1762. doi: 10.1017/S0950268817000516. Epub 2017 Mar 15.
Zotero 插件